AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35460726 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO) + NrtI
Number of subjects: 73
Study 35460726 — intervention group
Group type: EXPERIMENTAL
Intervention: Vebicorvir (VBR) + NrtI
Number of subjects: 73
Study 32818353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral moxifloxacin (0.03 mL, 150 μg in 0.03 mL Vigamox solution)
Number of subjects: 93
Study 32818353 — intervention group
Group type: COMPARATOR
Intervention: Control group (no moxifloxacin)
Number of subjects: 93
Study 35477618 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine Extended-Release Tablet (AMPH ER TAB) 5 mg starting dose, titrated to 20 mg
Number of subjects: 100
Study 35477618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33872196 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) gauze pad (0.05% HA)
Number of subjects: 168
Study 33872196 — intervention group
Group type: COMPARATOR
Intervention: Neutral gauze pad (without HA)
Number of subjects: 168
Study 33481840 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC-NOSF dressings
Number of subjects: 0
Study 33481840 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC-NOSF dressings (initiated within two months)
Number of subjects: 0
Study 33481840 — intervention group
Group type: COMPARATOR
Intervention: Neutral dressings
Number of subjects: 0
Study 32201975 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletics health guidance (AHG)
Number of subjects: 0
Study 32201975 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory action research (PAR)
Number of subjects: 0
Study 32201975 — intervention group
Group type: EXPERIMENTAL
Intervention: AHG areas of focus
Number of subjects: 0
Study 32201975 — intervention group
Group type: EXPERIMENTAL
Intervention: Best practice guidelines
Number of subjects: 0
Study 35801274 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B (PolyB 6000 IU/kg IV, 7 doses q12h)
Number of subjects: 6
Study 35801274 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B/gentamicin (PolyB 6000 IU/kg IV, q12h 7 doses; gentamicin 10 mg/kg IV q24h 4 doses)
Number of subjects: 6
Study 35801274 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B/gentamicin
Number of subjects: 6
Study 33813779 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning algorithm using convolutional neural networks (CNN) for glomerulus detection
Number of subjects: 71
Study 35417771 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention‐Medication Therapy Management (BI‐MTM)
Number of subjects: 350
Study 35417771 — intervention group
Group type: COMPARATOR
Intervention: Standard Medication Counseling (SMC)
Number of subjects: 350
Study 32461125 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal injection of glucocorticoids (50mg prednisolone acetate), n=24
Number of subjects: 50
Study 32461125 — intervention group
Group type: COMPARATOR
Intervention: Intradiscal injection of lidocaine (40mg), n=26
Number of subjects: 50
Study 32505660 — intervention group
Group type: EXPERIMENTAL
Intervention: Active theta tACS stimulation (1 mA peak-to-peak intensity for approximately 20 min)
Number of subjects: 26
Study 32505660 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (30 s duration)
Number of subjects: 26
Study 35167913 — intervention group
Group type: COMPARATOR
Intervention: Tension band wire technique (TBW)
Number of subjects: 20
Study 35167913 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension band tape technique (TBT)
Number of subjects: 20
Study 34196004 — intervention group
Group type: EXPERIMENTAL
Intervention: YouTube video content analysis
Number of subjects: 136
Study 32594139 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS) for five days
Number of subjects: 30
Study 32594139 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (tDCS)
Number of subjects: 30
Study 34025075 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment group (30-g or 60-g superdonor faeces)
Number of subjects: 164
Study 34025075 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (own faeces)
Number of subjects: 164
Study 33791095 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment (duration not specified)
Number of subjects: 0
Study 33791095 — intervention group
Group type: COMPARATOR
Intervention: Children with chest-indrawing pneumonia and comorbidities (HIV infection or exposure, malaria, moderate or severe acute malnutrition)
Number of subjects: 0
Study 32844549 — intervention group
Group type: EXPERIMENTAL
Intervention: Computable phenotype algorithm for resistant hypertension (RHTN)
Number of subjects: 156730
Study 32844549 — intervention group
Group type: EXPERIMENTAL
Intervention: Computable phenotype algorithm for stable controlled hypertension (HTN)
Number of subjects: 156730
Study 32844549 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrater reliability (IRR) analysis
Number of subjects: 156730
Study 34981245 — intervention group
Group type: EXPERIMENTAL
Intervention: Noble metal alloy (NMA) coated endotracheal tubes (ETT)
Number of subjects: 323
Study 34981245 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-coated endotracheal tubes)
Number of subjects: 323
Study 32655260 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended lymphadenectomy including para-aortic lymph nodes dissection
Number of subjects: 0
Study 32655260 — intervention group
Group type: COMPARATOR
Intervention: Radical resection combined with postoperative adjuvant chemotherapy
Number of subjects: 0
Study 36137731 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ACL reconstruction (n=85)
Number of subjects: 167
Study 36137731 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation therapy plus optional delayed ACL reconstruction (n=82)
Number of subjects: 167
Study 36137731 — intervention group
Group type: COMPARATOR
Intervention: Patients who received no ACL reconstruction (n=41)
Number of subjects: 167
Study 36137731 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who received early ACL reconstruction (n=82) and patients that received delayed ACL reconstruction (n=41)
Number of subjects: 167
Study 34286901 — intervention group
Group type: EXPERIMENTAL
Intervention: Group U + CHX (universal adhesive with chlorhexidine pretreatment)
Number of subjects: 75
Study 34286901 — intervention group
Group type: COMPARATOR
Intervention: Group C (no IDS)
Number of subjects: 75
Study 34286901 — intervention group
Group type: EXPERIMENTAL
Intervention: Group ER + CHX (etch & rinse adhesive with chlorhexidine pretreatment)
Number of subjects: 75
Study 34286901 — intervention group
Group type: EXPERIMENTAL
Intervention: Group ER (etch & rinse adhesive without chlorhexidine pretreatment)
Number of subjects: 75
Study 34286901 — intervention group
Group type: EXPERIMENTAL
Intervention: Group U (universal adhesive without chlorhexidine pretreatment)
Number of subjects: 75
Study 35021915 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (20-30°C for 20 minutes/day for 4 weeks)
Number of subjects: 76
Study 33225615 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (24-IU single-dose intranasal)
Number of subjects: 10
Study 33225615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33731168 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone turnover marker (BTM) monitoring with alendronate, calcitriol, and calcium; medication duration was prolonged based on BTM results.
Number of subjects: 0
Study 33731168 — intervention group
Group type: COMPARATOR
Intervention: Control group received oral medication (alendronate, calcitriol, and calcium) for a uniform duration of 3 months.
Number of subjects: 0
Study 32220693 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic bacteriuria positive group (ASB positive)
Number of subjects: 1610
Study 32220693 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic bacteriuria negative group (ASB negative)
Number of subjects: 1610
Study 32220693 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with ASB but not a short CL
Number of subjects: 1610
Study 32220693 — intervention group
Group type: EXPERIMENTAL
Intervention: Women without ASB and no short CL
Number of subjects: 1610
Study 33479040 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care package delivered by non-physicians
Number of subjects: 120
Study 33479040 — intervention group
Group type: COMPARATOR
Intervention: Standard care from outpatient physicians
Number of subjects: 120
Study 32934804 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg nefopam before surgical incision and normal saline before the end of surgery (Nefopam-Placebo)
Number of subjects: 96
Study 32934804 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline before surgical incision and 30 mg of nefopam before the end of surgery (Placebo-Nefopam)
Number of subjects: 96
Study 32934804 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg nefopam in both timings (Nefopam-Nefopam)
Number of subjects: 96
Study 32934804 — intervention group
Group type: COMPARATOR
Intervention: Normal saline before surgical incision and before the end of surgery (Placebo-Placebo)
Number of subjects: 96
Study 33502244 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional loneliness
Number of subjects: 3821
Study 33502244 — intervention group
Group type: EXPERIMENTAL
Intervention: Social loneliness
Number of subjects: 3821
Study 33502244 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional social support and quality of life
Number of subjects: 3821
Study 33502244 — intervention group
Group type: EXPERIMENTAL
Intervention: Social capital in the neighbourhood, companionship, and instrumental support
Number of subjects: 3821
Study 33502244 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic variables
Number of subjects: 3821
Study 34532085 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 86
Study 35655244 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacist intervention (active collection of information from family physicians and care managers)
Number of subjects: 18
Study 35655244 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal duties of pharmacists)
Number of subjects: 18
Study 33310802 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine programme (electroanalgesia and McKenzie method exercises)
Number of subjects: 540
Study 33310802 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face programme (electroanalgesia and McKenzie method exercises)
Number of subjects: 540
Study 36066959 — intervention group
Group type: EXPERIMENTAL
Intervention: AI interpretation (automated machine translation) during psychiatric interviews
Number of subjects: 6
Study 36066959 — intervention group
Group type: COMPARATOR
Intervention: Human interpretation (Spanish-speaking human interpreter) during psychiatric interviews
Number of subjects: 6
Study 36066959 — intervention group
Group type: EXPERIMENTAL
Intervention: AI interpretation via videoconferencing
Number of subjects: 6
Study 34462252 — intervention group
Group type: EXPERIMENTAL
Intervention: AVAPS
Number of subjects: 80
Study 34462252 — intervention group
Group type: COMPARATOR
Intervention: S/T
Number of subjects: 80
Study 35108492 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (3 hypnotherapy sessions, once a month)
Number of subjects: 104
Study 35108492 — intervention group
Group type: COMPARATOR
Intervention: Control (health education: diet + exercise + behavioral recommendations)
Number of subjects: 104
Study 35108492 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnosis (practiced frequently by participants in IG)
Number of subjects: 104
Study 35108492 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 104
Study 33388929 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic-strength training program
Number of subjects: 32
Study 33388929 — intervention group
Group type: COMPARATOR
Intervention: Flexibility training (stretching control group)
Number of subjects: 32
Study 33571293 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis (0.5 g dried cannabis flowers with 80 mg THC)
Number of subjects: 32
Study 33571293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 32468687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention (four nutrition classes and monthly home visits by cadres)
Number of subjects: 266
Study 32468687 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard monthly health care at the health post)
Number of subjects: 266
Study 32468687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 266
Study 35644694 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubiquinol and D-ribose
Number of subjects: 216
Study 35644694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 32390120 — intervention group
Group type: EXPERIMENTAL
Intervention: OWHTO and arthroscopic all‐inside meniscal repair (Group A, n=30)
Number of subjects: 90
Study 32390120 — intervention group
Group type: COMPARATOR
Intervention: OWHTO only (Group B, n=34)
Number of subjects: 90
Study 32390120 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (Group C, n=26)
Number of subjects: 90
Study 33021355 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 0
Study 33021355 — intervention group
Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 0
Study 34329337 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-MAP with 15 μg HA
Number of subjects: 10
Study 34329337 — intervention group
Group type: COMPARATOR
Intervention: Uncoated placebo HD-MAPs
Number of subjects: 10
Study 32304710 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin group (pre-soaked in 5mg/ml vancomycin for 10 minutes)
Number of subjects: 30
Study 32304710 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-soaked in physiological serum for 10 minutes)
Number of subjects: 30
Study 36096387 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 77
Study 36096387 — intervention group
Group type: COMPARATOR
Intervention: Zoledronate
Number of subjects: 77
Study 32019483 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide-related news articles
Number of subjects: 420
Study 32019483 — intervention group
Group type: COMPARATOR
Intervention: Neutral news articles
Number of subjects: 420
Study 35189939 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid endoscopic submucosal dissection (H‐ESD)
Number of subjects: 82
Study 35189939 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic submucosal dissection (C‐ESD)
Number of subjects: 82
Study 34321092 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking prescription of 150 min/week during pre-surgical waiting time
Number of subjects: 368
Study 34321092 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 368
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Elder Life Program (HELP)‐based paging system
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Family‐based paging system
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HELP‐ and family‐based system
Number of subjects: 60
Study 32934794 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: HELP-based paging system
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based paging system
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory outcomes
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital Elder Life Program (HELP)-based paging system
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HELP- and family-based system
Number of subjects: 60
Study 32934794 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care, HELP-based paging system, family-based paging system, combined HELP- and family-based system
Number of subjects: 60
Study 36237582 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuanghuanghua granules (ultrafine preparation)
Number of subjects: 126
Study 36237582 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuanghuanghua granules (extract preparation)
Number of subjects: 126
Study 36237582 — intervention group
Group type: COMPARATOR
Intervention: Fengreganmao granules
Number of subjects: 126
Study 32395750 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural cycle frozen embryo transfer (NC-FET)
Number of subjects: 248
Study 32395750 — intervention group
Group type: COMPARATOR
Intervention: Modified natural cycle frozen embryo transfer (modified NC-FET) with subcutaneous hCG injection to trigger ovulation
Number of subjects: 248
Study 32395750 — intervention group
Group type: COMPARATOR
Intervention: Modified natural cycle frozen embryo transfer (modified NC-FET)
Number of subjects: 248
Study 34246214 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine fumarate
Number of subjects: 0
Study 34246214 — intervention group
Group type: COMPARATOR
Intervention: Bepotastine besilate
Number of subjects: 0
Study 34246214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32017251 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based program (4 education modules)
Number of subjects: 71
Study 32017251 — intervention group
Group type: COMPARATOR
Intervention: Routine care in clinics (control group)
Number of subjects: 71
Study 35414541 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness course for 4 weeks
Number of subjects: 240
Study 35414541 — intervention group
Group type: COMPARATOR
Intervention: Light physical exercise course for 4 weeks
Number of subjects: 240
Study 34655533 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab plus lenalidomide and dexamethasone
Number of subjects: 737
Study 34655533 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide and dexamethasone alone (control group)
Number of subjects: 737
Study 32702919 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization
Number of subjects: 147
Study 32702919 — intervention group
Group type: EXPERIMENTAL
Intervention: Early nutrition combined with early mobilization
Number of subjects: 147
Study 32702919 — intervention group
Group type: COMPARATOR
Intervention: Standard care (minimal exercises, experience‐based initiation and enrollment of nutrition support)
Number of subjects: 147
Study 33560052 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/day (n=2903)
Number of subjects: 30937
Study 33560052 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/day (n=8407)
Number of subjects: 30937
Study 33560052 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of telmisartan 80 mg/day and ramipril 10 mg/day (n=8334)
Number of subjects: 30937
Study 33560052 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=2907)
Number of subjects: 30937
Study 33560052 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved SBP levels
Number of subjects: 30937
Study 33027246 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Quality Improvement (CQI) intervention delivered by trained mentors using standard CQI tools over 19 months.
Number of subjects: 2160
Study 33027246 — intervention group
Group type: COMPARATOR
Intervention: Usual standard of antenatal care (ANC) as control.
Number of subjects: 2160
Study 35986410 — intervention group
Group type: EXPERIMENTAL
Intervention: Early CRRT
Number of subjects: 496
Study 35986410 — intervention group
Group type: COMPARATOR
Intervention: Conventional-indicated CRRT
Number of subjects: 496
Study 35986410 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker
Number of subjects: 496
Study 35986410 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 496
Study 34809689 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented Rhus verniciflua Stokes extract (FRVE) - 129 mg fustin and 59 mg fisetin, taken as two capsules once daily for 12 weeks
Number of subjects: 79
Study 34809689 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose 627.0 mg), taken as two capsules once daily for 12 weeks
Number of subjects: 79
Study 32659856 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower arterial oxygenation target (8 kPa)
Number of subjects: 0
Study 32659856 — intervention group
Group type: COMPARATOR
Intervention: Higher arterial oxygenation target (12 kPa)
Number of subjects: 0
Study 35731337 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group A (1st set of 25 cases)
Number of subjects: 100
Study 35731337 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group B (2nd set of 25 cases)
Number of subjects: 100
Study 35731337 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group C (3rd set of 25 cases)
Number of subjects: 100
Study 35731337 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group A
Number of subjects: 100
Study 35731337 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group B
Number of subjects: 100
Study 35731337 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic assisted Total Knee Arthroplasty - Group C
Number of subjects: 100
Study 35731337 — intervention group
Group type: COMPARATOR
Intervention: Conventional jig-based Total Knee Arthroplasty
Number of subjects: 100
Study 34111066 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Number of subjects: 56
Study 34111066 — intervention group
Group type: COMPARATOR
Intervention: Mulligan mobilisation
Number of subjects: 56
Study 35329194 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-week functional core stability training (CST) program based on rhythmic gymnastics technical requirements added to traditional RG training sessions.
Number of subjects: 45
Study 35329194 — intervention group
Group type: COMPARATOR
Intervention: Traditional RG training sessions (Control Group).
Number of subjects: 45
Study 35329194 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EG and CG).
Number of subjects: 45
Study 34089698 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal fetoscopic repair of open spina bifida
Number of subjects: 300
Study 34089698 — intervention group
Group type: COMPARATOR
Intervention: Management of Myelomeningocele Study
Number of subjects: 300